Compare IQV & BAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IQV | BAP |
|---|---|---|
| Founded | 1982 | 1889 |
| Country | United States | Peru |
| Employees | 93000 | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.6B | 30.5B |
| IPO Year | 2013 | 1997 |
| Metric | IQV | BAP |
|---|---|---|
| Price | $203.92 | $381.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 5 |
| Target Price | $227.13 | ★ $309.60 |
| AVG Volume (30 Days) | ★ 1.5M | 457.1K |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 3.46% |
| EPS Growth | ★ 4.67 | N/A |
| EPS | ★ 1.61 | N/A |
| Revenue | ★ $9,739,000,000.00 | N/A |
| Revenue This Year | $6.77 | $23.26 |
| Revenue Next Year | $5.89 | $8.62 |
| P/E Ratio | $129.54 | ★ $12.91 |
| Revenue Growth | ★ 41.60 | N/A |
| 52 Week Low | $154.50 | $216.87 |
| 52 Week High | $247.05 | $423.17 |
| Indicator | IQV | BAP |
|---|---|---|
| Relative Strength Index (RSI) | 66.57 | 56.95 |
| Support Level | $159.91 | $312.40 |
| Resistance Level | $209.48 | $423.17 |
| Average True Range (ATR) | 7.02 | 14.85 |
| MACD | 2.45 | -0.69 |
| Stochastic Oscillator | 84.77 | 21.48 |
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
Credicorp Ltd is a Peruvian financial services company. The company operates in four business lines, including Universal Banking, Insurance and Retirement, Microfinance, and Investment Banking and Asset Management. Its subsidiaries include Banco de Credito del Peru, Prima AFP, Credicorp Capital, and others. Geographically, the company operates in Peru, Colombia, Bolivia, Chile, Panama, the USA, and Mexico; the majority of its revenue is generated from Peru.